Fabry disease and early stroke

Stroke Research and Treatment

Volumn , Issue , 2011, Pages

  Feldt Rasmussen, U ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE BETA; ALPHA GALACTOSIDASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; CHAPERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSPHINGOLIPID; VITAMIN D RECEPTOR;

ADJUVANT THERAPY; ANHIDROSIS; BLOOD PRESSURE REGULATION; BRAIN ISCHEMIA; CORNEA OPACITY; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; ENZYME REPLACEMENT; FABRY DISEASE; GENE THERAPY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; LIFESTYLE MODIFICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING; VASCULAR DISEASE;

EID: 80052759087     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.4061/2011/615218     Document Type: Review

References (58)

1. Desnick R. J., Yannis I. A., Eng C. M., Scriver C. R., Beaudet A. L., Sly W. S., -galactosidase a deficiency: Fabry disease The Metabolic and Molecular Basis of Inherited Disease 2001 New York, NY, USA McGraw-Hill 3733 3774
2. Vedder A. C., Linthorst G. E., van Breemen M. J., Groener J. E. M., Bemelman F. J., Strijland A., Mannens M. M. A. M., Aerts J. M. F. G., Hollak C. E. M., The Dutch Fabry cohort: diversity of clinical manifestations and Gb levels Journal of Inherited Metabolic Disease 2007 30 1 68 78 (Pubitemid 46140228)
3. MacDermot K. D., Holmes A., Miners A. H., Natural history of Fabry disease in affected males and obligate carrier females Journal of Inherited Metabolic Disease 2001 24 2, supplement 13 14 (Pubitemid 33061626)
4. Schiffmann R., Warnock D. G., Banikazemi M., Bultas J., Linthorst G. E., Packman S., Sorensen S. A., Wilcox W. R., Desnick R. J., Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy Nephrology Dialysis Transplantation 2009 24 7 2102 2111
5. MacDermot K. D., Holmes A., Miners A. H., Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females Journal of Medical Genetics 2001 38 11 769 775 (Pubitemid 33032933)
6. Zarate Y. A., Hopkin R. J., Fabry's disease The Lancet 2008 372 9647 1427 1435
7. Sims K., Politei J., Banikazemi M., Lee P., Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the fabry registry Stroke 2009 40 3 788 794
8. Mehta A., Ricci R., Widmer U., Dehout F., Garcia De Lorenzo A., Kampmann C., Linhart A., Sunder-Plassmann G., Ries M., Beck M., Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey European Journal of Clinical Investigation 2004 34 3 236 242 (Pubitemid 38406640)
9. Wilcox W. R., Oliveira J. P., Hopkin R. J., Ortiz A., Banikazemi M., Feldt-Rasmussen U., Sims K., Waldek S., Pastores G. M., Lee P., Eng C. M., Marodi L., Stanford K. E., Breunig F., Wanner C., Warnock D. G., Lemay R. M., Germain D. P., Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry Molecular Genetics and Metabolism 2008 93 2 112 128
10. Fellgiebel A., Mller M. J., Ginsberg L., CNS manifestations of Fabry's disease Lancet Neurology 2006 5 9 791 795 (Pubitemid 44205515)
11. Albrecht J., Dellani P. R., Mller M. J., Schermuly I., Beck M., Stoeter P., Gerhard A., Fellgiebel A., Voxel based analyses of diffusion tensor imaging in Fabry disease Journal of Neurology, Neurosurgery and Psychiatry 2007 78 9 964 969 (Pubitemid 47310833)
12. Eng C. M., Fletcher J., Wilcox W. R., Waldek S., Scott C. R., Sillence D. O., Breunig F., Charrow J., Germain D. P., Nicholls K., Banikazemi M., Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry Journal of Inherited Metabolic Disease 2007 30 2 184 192 (Pubitemid 46487999)
13. Rombach S. M., Twickler T. B., Aerts J. M. F. G., Linthorst G. E., Wijburg F. A., Hollak C. E. M., Vasculopathy in patients with Fabry disease: current controversies and research directions Molecular Genetics and Metabolism 2010 99 2 99 108
14. Thurberg B. L., Rennke H., Colvin R. B., Dikman S., Gordon R. E., Collins A. B., Desnick R. J., O'Callaghan M., Globotriaosylceramide accumulation in the fabry kidney is cleared from multiple cell types after enzyme replacement therapy Kidney International 2002 62 6 1933 1946 (Pubitemid 35366149)
15. Thurberg B. L., Byers H. R., Granter S. R., Phelps R. G., Gordon R. E., O'Callaghan M., Monitoring the 3-year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies Journal of Investigative Dermatology 2004 122 4 900 908 (Pubitemid 38580992)
16. Thurberg B. L., Fallen J. T., Mitchell R., Aretz T., Gordon R. E., O'Callaghan M. W., Cardiac microvascular pathology in fabry disease evaluation of endomyocardial biopsies before and after enzyme replacement therapy Circulation 2009 119 19 2561 2567
17. Breunig F., Wanner C., Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy Journal of Nephrology 2008 21 1 32 37 (Pubitemid 351780571)
18. Wilcox W. R., Banikazemi M., Guffon N., Waldek S., Lee P., Linthorst G. E., Desnick R. J., Germain D. P., Long-term safety and efficacy of enzyme replacement therapy for Fabry disease American Journal of Human Genetics 2004 75 1 65 74
19. Weidemann F., Niemann M., Breunig F., Herrmann S., Beer M., Strk S., Voelker W., Ertl G., Wanner C., Strotmann J., Long-term effects of enzyme replacement therapy on fabry cardiomyopathy. Evidence for a better outcome with early treatment Circulation 2009 119 4 524 529
20. Moore D. F., Kaneski C. R., Askari H., Schiffmann R., The cerebral vasculopathy of Fabry disease Journal of the Neurological Sciences 2007 257 1-2 258 263 (Pubitemid 46856501)
21. Hilz M. J., Kolodny E. H., Brys M., Stemper B., Haendl T., Marthol H., Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease Journal of Neurology 2004 251 5 564 570 (Pubitemid 38680299)
22. DeGraba T., Azhar S., Dignat-George F., Brown E., Boutire B., Altarescu G., McCarron R., Schiffmann R., Profile of endothelial and leukocyte activation in Fabry patients Annals of Neurology 2000 47 2 229 233 (Pubitemid 30078570)
23. Moore D. F., Herscovitch P., Schiffmann R., Selective arterial distribution of cerebral hyperperfusion in fabry disease Journal of Neuroimaging 2001 11 3 303 307 (Pubitemid 32625278)
24. Moore D. F., Ye F., Brennan M. L., Gupta S., Barshop B. A., Steiner R. D., Rhead W. J., Brady R. O., Hazen S. L., Schiffmann R., Ascorbate decreases fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study Journal of Magnetic Resonance Imaging 2004 20 4 674 683 (Pubitemid 39313744)
25. Weidemann F., Linhart A., Monserrat L., Strotmann J., Cardiac challenges in patients with Fabry disease International Journal of Cardiology 2010 141 1 3 10
26. Crutchfield K. E., Patronas N. J., Dambrosia J. M., Frei K. P., Banerjee T. K., Barton N. W., Schiffmann R., Quantitative analysis of cerebral vasculopathy in patients with Fabry disease Neurology 1998 50 6 1746 1749 (Pubitemid 28283245)
27. Grewal R. P., McLatchey S. K., Cerebrovascular manifestations in a female carrier of Fabry's disease Acta Neurologica Belgica 1992 92 1 36 40
28. Mitsias P., Levine S. R., Cerebrovascular complications of Fabry's disease Annals of Neurology 1996 40 1 8 17 (Pubitemid 26250137)
29. Moore D. F., Altarescu G., Barker W. C., Patronas N. J., Herscovitch P., Schiffmann R., White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions Brain Research Bulletin 2003 62 3 231 240 (Pubitemid 38091711)
30. Tedeschi G., Bonavita S., Banerjee T. K., Virta A., Schiffmann R., Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study Neurology 1999 52 8 1663 1667 (Pubitemid 29220645)
31. Marino S., Borsini W., Buchner S., Mortilla M., Stromillo M. L., Battaglini M., Giorgio A., Bramanti P., Federico A., De Stefano N., Diffuse structural and metabolic brain changes in Fabry disease Journal of Neurology 2006 253 4 434 440 (Pubitemid 43965607)
32. Moore D. F., Ye F., Schiffmann R., Butman J. A., Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease American Journal of Neuroradiology 2003 24 6 1096 1101 (Pubitemid 36734228)
33. Burlina A. P., Manara R., Caillaud C., Laissy J. P., Severino M., Klein I., Burlina A., Lidove O., The pulvinar sign: frequency and clinical correlations in Fabry disease Journal of Neurology 2008 255 5 738 744
34. Fellgiebel A., Keller I., Marin D., Mller M. J., Schermuly I., Yakushev I., Albrecht J., Bellhuser H., Kinateder M., Beck M., Stoeter P., Diagnostic utility of different MRI and MR angiography measures in Fabry disease Neurology 2009 72 1 63 68
35. Gupta S., Ries M., Kotsopoulos S., Schiffmann R., The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women Medicine 2005 84 5 261 268 (Pubitemid 41368479)
36. Grewal R. P., Stroke in Fabry's disease Journal of Neurology 1994 241 3 153 156 (Pubitemid 24026826)
37. Mehta A., Ginsberg L., Natural history of the cerebrovascular complications of Fabry disease Acta Paediatrica 2005 94 447 24 27
38. Rolfs A., Bttcher T., Zschiesche M., Morris P., Winchester B., Bauer P., Walter U., Mix E., Lhr M., Harzer K., Strauss U., Pahnke J., Grossmann A., Benecke R., Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study Lancet 2005 366 9499 1794 1796 (Pubitemid 41642643)
39. Schiffmann R., Ries M., Fabry's diseasean important risk factor for stroke Lancet 2005 366 9499 1754 1756 (Pubitemid 41642633)
40. Brouns R., Sheorajpanday R., Braxel E., Eyskens F., Baker R., Hughes D., Mehta A., Timmerman T., Vincent M. F., De Deyn P. P., Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke Clinical Neurology and Neurosurgery 2007 109 6 479 484 (Pubitemid 46783192)
41. Baptista M. V., Ferreira S., Pinho-E-Melo T., Carvalho M., Cruz V. T., Carmona C., Silva F. A., Tuna A., Rodrigues M., Ferreira C., Pinto A. A.N., Leito A., Gabriel J. P., Calado S., Oliveira J. P., Ferro J. M., Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE studyscreening genetic conditions in Portuguese young STROKE patients Stroke 2010 41 3 431 436
42. Wozniak M. A., Kittner S. J., Tuhrim S., Cole J. W., Stern B., Dobbins M., Grace M. E., Nazarenko I., Dobrovolny R., McDade E., Desnick R. J., Frequency of unrecognized fabry disease among young european-american and african-american men with first ischemic stroke Stroke 2010 41 1 78 81
43. Wang R. Y., Lelis A., Mirocha J., Wilcox W. R., Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life Genetics in Medicine 2007 9 1 34 45 (Pubitemid 46115959)
44. Galanos J., Nicholls K., Grigg L., Kiers L., Crawford A., Becker G., Clinical features of Fabry's disease in Australian patients Internal Medicine Journal 2002 32 12 575 584 (Pubitemid 36871740)
45. Desnick R. J., Allen K. Y., Desnick S. J., Raman M. K., Bernlohr R. W., Krivit W., Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. -Galactosidase activities in plasma, serum, urine, and leukocytes The Journal of Laboratory and Clinical Medicine 1973 81 2 157 171
46. Linthorst G. E., Poorthuis B. J. H. M., Enzyme activity for determination of presence of Fabry disease in women results in 40 false-negative results Journal of the American College of Cardiology 2008 51 21 2082 (Pubitemid 351680525)
47. van den Veyver I. B., Skewed X inactivation in X-linked disorders Seminars in Reproductive Medicine 2001 19 183 191
48. Hwu W. L., Chien Y. H., Lee N. C., Chiang S. C., Dobrovolny R., Huang AI. C., Yeh H. Y., Chao M. C., Lin S. J., Kitagawa T., Desnick R. J., Hsu LI. W., Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c. 936+919GA(IVS4+919GA) Human mutation 2009 30 10 1397 1405
49. Lin H. Y., Chong K. W., Hsu J. H., Yu H. C., Shih C. C., Huang C. H., Lin S. J., Chen C. H., Chiang C. C., Ho H. J., Lee PI. C., Kao C. H., Cheng K. H., Hsueh C., Niu D. M., High incidence of the cardiac variant of fabry disease revealed by newborn screening in the Taiwan Chinese population Circulation 2009 2 5 450 456
50. Spada M., Pagliardini S., Yasuda M., Tukel T., Thiagarajan G., Sakuraba H., Ponzone A., Desnick R. J., High incidence of later-onset Fabry disease revealed by newborn screening American Journal of Human Genetics 2006 79 1 31 40 (Pubitemid 43927374)
51. Linthorst G. E., Bouwman M. G., Wijburg F. A., Aerts J. M. F. G., Poorthuis B. J. H. M., Hollak C. E. M., Screening for Fabry disease in high-risk populations: a systematic review Journal of Medical Genetics 2010 47 4 217 222
52. Rolfs A., Martus P., Heuschmann P. U., Grittner U., Holzhausen M., Tatlisumak T., Bttcher T., Fazekas F., Enzinger C., Ropele S., Schmidt R., Riess O., Norrving B., Protocol and methodology of the stroke in young fabry patients (sifap1) study: a prospective multicenter european study of 5,024 young stroke patients aged 1855 years Cerebrovascular Diseases 2011 31 3 253 262
53. Eng C. M., Guffon N., Wilcox W. R., Germain D. P., Lee P., Waldek S., Caplan L., Linthorst G. E., Desnick R. J., Safety and efficacy of recombinant human -galactosidase a replacement therapy in Fabry's disease New England Journal of Medicine 2001 345 1 9 16 (Pubitemid 32634266)
54. Rozenfeld P., Neumann P. M., Treatment of Fabry disease: current and emerging strategies Current Pharmaceutical Biotechnology 2011 12 6 916 922
55. Banikazemi M., Bultas J., Waldek S., Wilcox W. R., Whitley C. B., McDonald M., Finkel R., Packman S., Bichet D. G., Warnock D. G., Desnick R. J., Agalsidase-beta therapy for advanced fabry disease: a randomized trial Annals of Internal Medicine 2007 146 2 77 86 (Pubitemid 351640010)
56. Teitcher M., Weinerman S., Whybra C., Beck M., Sharon N., Elstein D., Altarescu G., Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease Genetica 2008 134 3 377 383
57. Gupta S., Ries M., Kotsopoulos S., Schiffmann R., The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women Medicine 2005 84 5 261 268 (Pubitemid 41368479)
58. Germain D. P., Waldek S., Banikazemi M., Bushinsky D. A., Charrow J., Desnick R. J., Lee P., Loew T., Vedder A. C., Abichandani R., Wilcox W. R., Guffon N., Sustained, long-term renal stabilization after 54 months of agalsidase therapy in patients with fabry disease Journal of the American Society of Nephrology 2007 18 5 1547 1557 (Pubitemid 46717522)